delayed injection site reaction semaglutide Semaglutide-induced fixed drug eruption TrimRX | Semaglutide Injection Site

Many patients face this challenge because most insurance companies require prior authorization (PA)

In this episode, we explore the use of GLP-1 therapy for weight management beyond diabetes, including who may benefit and who should avoid it.

A new biweekly GLP-1 shot has been shown to significantly lower blood sugar and aid weight loss in a clinical trial, offering benefits similar to Ozempic and Mounjaro with fewer injections.

Citing unprecedented demand, drugmaker Novo Nordisk said Thursday it expects supply restrictions on starter doses of the weight loss medicine Wegovy to persist into 2024, several months beyond its previous prediction.

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, others are continuing and pushing regulatory boundaries.